Blog
RSS FeedPosted by Michael Wonder on 11 Jul 2020
NICE backing for Takeda's Adcetris for rare lymphoma
10 July 2020 - Takeda's Adcetris (brentuximab vedotin) has won the backing of the National Institute for Health and Care ...
Posted by Michael Wonder on 09 Jul 2020
NICE signs agreement with Colombia’s Institute of Health Technology Assessment to forge closer working ties
9 July 2020 - Research and knowledge sharing key to collaborative working approach agreed the two agencies. ...
Posted by Michael Wonder on 05 Jul 2020
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals
3 July 2020 - Economic models play a central role in the decision-making process of NICE. ...
Posted by Michael Wonder on 02 Jul 2020
Vertex announces expansion of reimbursement agreement with NHS England to include Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor)
30 June 2020 - Cystic fibrosis patients in England will be among the first in Europe to benefit from access to ...
Posted by Michael Wonder on 01 Jul 2020
NICE publishes final guidance for Tecentriq for 2 indications
1 July 2020 - NICE has released final guidance on the use of atezolizumab by patients with small cell lung ...
Posted by Michael Wonder on 30 Jun 2020
After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
30 June 2020 - U.K. officials and Vertex Pharmaceuticals have finally put to rest a years-long battle over access to ...
Posted by Michael Wonder on 25 Jun 2020
NICE draft guidance does not recommend siponimod for treating secondary progressive multiple sclerosis
25 June 2020 - NICE has today issued draft guidance for public consultation which does not recommend siponimod (Mayzent, Novartis) for ...
Posted by Michael Wonder on 25 Jun 2020
Cancer patients to benefit from new histology independent treatment
25 June 2020 - Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug ...
Posted by Michael Wonder on 24 Jun 2020
NICE publishes final guidance for Sobi's avatrombopag maleate
24 June 2020 - Avatrombopag maleate is used to treat patients with thrombocytopenia. ...
Posted by Michael Wonder on 24 Jun 2020
NICE begins phased restart of non-COVID-19 guidance
24 June 2020 - NICE has begun a phased restart of publishing non-COVID-19 guidance as the NHS and wider health ...
Posted by Michael Wonder on 18 Jun 2020
Government authorises use of dexamethasone for COVID-19
18 June 2020 - The UK has authorised immediate use of dexamethasone on the NHS, widening access to the first ...
Posted by Michael Wonder on 18 Jun 2020
UK launches world's first ‘subscription-style’ payment model for antibiotics
18 June 2020 - A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies ...
Posted by Michael Wonder on 17 Jun 2020
Disagreement on cancer drug decisions in Europe
15 June 2020 - Despite the efforts of the European Union to promote voluntary cooperation among Health Technology Assessment agencies, different ...
Posted by Michael Wonder on 17 Jun 2020
Final NICE green light for Janssen's Stelara in ulcerative colitis
17 June 2020 - NICE has now issued a final green light for NHS use of Janssen's Stelara (ustekinumab) to ...
Posted by Michael Wonder on 15 Jun 2020
NICE backs Rozlytrek for subset of NSCLC patients
15 June 2020 - NICE has published final draft guidance backing NHS use of Roche's Rozlytrek (entrectinib) as a treatment ...